SecBot SecBot

NXGLW

NEXGEL, INC.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001468929 Healthcare & Medical Devices
Warrants of NEXGEL, INC. · NXGL stock page →
—
Market cap
$3.7K
Nano cap
1 year
−92.1%
from $51.60 · Oct 27
30 days
+13.9%
from $3.56
52-week range
$3.00–51.60
−92% from high · low Oct 8
Avg volume 20D
240.4K
Oct 14 spike 3.34M
Short interest
🔒 Subscribers only
New fund stakes
0
Q1 2026 13F · 0 exits
Filing reports
4
analyzed by SecBot
SecBot read BEARISH 4 reports · latest
Balance 3 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 4/4
Strongest BEARISH NEXGEL entered into a securities purchase agreement to issue unsecured convertible promissory notes and…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q1 2026: 1 added (0 new), 0 trimmed or exited.

  • TrendRANGE

    25% below its 50-day average.

Who's buying

13F· Q1 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGDOUBLED16,081$724.00
UBS Group AGDOUBLED1,199$282.00
UBS Group AGTRIM339$102.00
UBS Group AGNEAR_EXIT1,339$335.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 27, 2026
Press release
🔒 Fresh data, subscribers only
Oct 12, 2026
Trading halt
Halt Resumed: NXGLW — trading resumed after T3 (News and Resumption Times)
Halted 2026-10-09T23:50:00.000Z | Resumed 2026-10-12T13:05:00.000Z
Oct 9, 2026
Trading halt
Trading Halt: NXGLW — T3 (News and Resumption Times)
NexGel, Inc | Market: NASDAQ | Code: T3 — News and Resumption Times
Sep 23, 2026
Press release
NEXGEL Announces Dial-In Details for Investor Update Call
LANGHORNE, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric…
May 12, 2026
Earnings
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
Management Will Host a Conference Call at 12:00 P.M. ET on the Same Day

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$4.2M
Next Q———$5.3M
Current FY———$15.8M
Next FY———$24.3M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Trading halts
Oct 9, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 27, 2026 Other
🔒 Fresh data, subscribers only
May 15, 2026 SEC
NEXGEL entered into a securities purchase agreement to issue unsecured convertible promissory notes and warrants in an…
8-K — Impact 7/10
Apr 30, 2026 SEC
NEXGEL appointed Ian Blackman as permanent CFO, replacing interim CFO Adam Drapczuk, with a $250,000 base salary and…
8-K — Impact 2/10
Apr 24, 2026 SEC
NexGel, Inc. received a Nasdaq deficiency notice because its common stock's closing bid price has been below $1.00 per…
8-K — Impact 8/10
Mar 31, 2026 Inst.
UBS Group AG — DOUBLED
16,081 shares ($724.00)
Dec 31, 2025 Inst.
UBS Group AG — DOUBLED
1,199 shares ($282.00)

SecBot reports

4 filings · 0 bullish · 3 bearish · 1 neutral
All NXGLW filing & press-release reports (4)